Summary
Axon Enterprise, Inc. reported strong growth in its second quarter of 2018, with total net sales increasing by 24.6% to $99.2 million compared to the prior year quarter. This growth was driven by robust performance in both its TASER Weapons segment, up 14.4%, and its Software and Sensors segment, which saw an impressive 45.0% increase. The company's strategic shift towards subscription-based revenue models is gaining traction, with a significant portion of sales now coming from contracts with multiple performance obligations. Net income more than tripled year-over-year to $8.5 million, reflecting improved gross margins and operational efficiencies, although operating expenses, particularly R&D, also increased as the company continues to invest in innovation and expansion. The balance sheet shows a significant increase in cash and cash equivalents to $307.5 million, largely due to proceeds from a follow-on equity offering in May 2018. The company also reported an increase in goodwill and intangible assets, indicating strategic acquisitions or business development activities. While the company faces ongoing litigation, management believes it will not materially impact financial condition. The company is also addressing a previously identified material weakness in internal controls related to its UK subsidiary through remediation efforts.
Financial Highlights
50 data points| Revenue | $99.23M |
| Cost of Revenue | $36.08M |
| Gross Profit | $63.14M |
| R&D Expenses | $18.50M |
| SG&A Expenses | $39.34M |
| Operating Expenses | $57.84M |
| Operating Income | $5.30M |
| Net Income | $8.48M |
| EPS (Basic) | $0.15 |
| EPS (Diluted) | $0.15 |
| Shares Outstanding (Basic) | 55.53M |
| Shares Outstanding (Diluted) | 57.05M |
Key Highlights
- 1Net sales increased by 24.6% to $99.2 million in Q2 2018 compared to Q2 2017.
- 2The Software and Sensors segment experienced substantial growth of 45.0% year-over-year, reaching $38.6 million in net sales.
- 3Net income grew significantly to $8.5 million, up from $2.3 million in the prior year quarter, with diluted EPS at $0.15.
- 4Cash and cash equivalents surged to $307.5 million as of June 30, 2018, up from $75.1 million at the end of 2017, bolstered by a recent equity offering.
- 5Gross margin improved to 63.6% from 57.3% in the prior year quarter, indicating better cost management and operational leverage.
- 6R&D expenses increased by 42.4% to $18.5 million, reflecting continued investment in product development, particularly in the Software and Sensors segment.
- 7The company is actively managing a material weakness in internal controls related to its UK subsidiary, implementing remediation steps.